Trial Information

Summary: A Study for the Treatment of Subjects with Fibromyalgia

This trial's participation duration is 21 weeks where subjects will be seen in the clinic for a total of 12 visits. Primary outcome is for a decrease in pain from fibromyalgia due to the study drug.

Patient Inclusion Criteria

• Male or female subject must be 18 years of age or older and meets the ACR criteria for fibromyalgia.
• Other inclusion criteria apply

Patient Exclusion Criteria

• Subject has Major Depressive Disorder, Bipolar, or other psychotic disorder and cannot safely discontinue use of antidepressant medication.
• Subject has Rheumatic disease in addition to fibromyalgia or other painful conditions that would interfere with the ability to measure change on any outcome measures associated with stiffness and muscle weakness.
• Other exclusion criteria apply

Qualified participants will receive, at not charge, study medication, study-related medical care, and laboratory evaluations.

If you are interested in this, or any other studies we currently have enrolling, please contact us for further information.

If you would like to learn more about participating in this study, please send an e-mail message using the form below.